Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 InfectionNeurology Published on 2021-02-102022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] Active surveillance Admission Affect anticoagulation Asymptomatic cerebral Cerebral venous thrombosis Clinical course Complication Concomitant COVID-19 COVID-19 infection COVID-19 patients CT scan Fever Galen headache Hypoxemia Infection internal internal iliac vein thrombosis interstitial pneumonia late phase low molecular weight malignancy massive neurologic neurological deficits outcome Patient Pelvic repeated respiratory symptoms SARS-CoV-2 SARS-COV-2 infection serological test silent subarachnoid hemorrhage Support Swab tested Thromboinflammation thrombosis thrombotic complication treated Treatment unfractionated heparin Vein venous Venous thrombosis with COVID-19 [DOI] 10.3389/fneur.2021.622130 PMC 바로가기 [Article Type] Neurology
Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectivesShort communication Published on 2021-02-012022-10-05 Journal: International journal of antimicrobial agents [Category] 치료법, [키워드] acute respiratory distress acute respiratory syndrome Asymptomatic caused complex coronavirus coronavirus disease Course COVID-19 Critical Critical illness Cytokine release syndrome death develop disease immune dysregulation immunomodulation immunosuppressive effect life-threatening management Manifestations Multisystem organ failure novel coronavirus SARS-CoV-2 Patient Perspective plasma exchange positive Randomised controlled trials Re-infection Real-time PCR reported resulting SARS-COV-2 infection Sepsis Spread syndrome the disease Therapeutic plasma exchange therapy thromboembolic disease Thromboinflammation TPE Treatment viral replication Wuhan, China [DOI] 10.1016/j.ijantimicag.2020.106273 [Article Type] Short communication
Thromboinflammation in COVID-19: Can α2 -macroglobulin help to control the fire?Article Published on 2021-02-012023-07-13 Journal: Journal of thrombosis and haemostasis : JTH [Category] SARS, [키워드] COVID-19 endothelial cells extracellular traps neutrophil Thromboinflammation α2-macroglobulin. [DOI] 10.1111/jth.15190 PMC 바로가기
Thromboinflammation and COVID-19: The Role of Exercise in the Prevention and TreatmentCardiovascular Medicine Published on 2020-12-182022-10-31 Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19, [키워드] COVID-19 Cytokine storm exercise pandemic prevention role Thromboinflammation [DOI] 10.3389/fcvm.2020.582824 PMC 바로가기 [Article Type] Cardiovascular Medicine
Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients만노스 결합 렉틴은 중환자 COVID-19 환자의 혈전증 및 응고증과 관련이 있습니다Article Published on 2020-12-012022-09-11 Journal: Thrombosis and haemostasis [Category] MERS, SARS, 바이오마커, 유전자 메커니즘, [키워드] Activation amplification Blood coagulation caused Coagulation Coagulopathy Cohort complement Complement activation complications contribute correlated COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients Critically ill critically ill COVID-19 patients D-dimer levels develop Effect elevated events hospital ICU ICU admission Ill increased risk Inflammation initiate intensive care Laboratory testing lectin lectin pathway mannose marker MBL pathway mechanism morbidity and mortality organ dysfunction pathological thrombosis Patient Pattern recognition pharmacological plasma risk significantly higher Society subset suggested symptomatic thromboembolic Thromboinflammation Thromboprophylaxis thrombosis treated Treatment [DOI] 10.1055/s-0040-1715835 PMC 바로가기 [Article Type] Article
Venous Thromboembolism in COVID-19COVID-19의 정맥 혈전색전증Review Published on 2020-12-012022-09-11 Journal: Thrombosis and haemostasis [Category] MERS, SARS, 바이오마커, [키워드] Biomarkers Characteristics Chemoprophylaxis coronavirus disease Coronavirus disease 2019 COVID-19 dose Evidence flu general treatment Guidance H1N1 hematological ill patient mechanism pandemic Pathogenesis patients with COVID-19 Prophylaxis Pulmonary embolism recommendation risk Risk assessment risk factor swine flu Thromboinflammation Treatment Venous Thromboembolism VTE [DOI] 10.1055/s-0040-1718532 PMC 바로가기 [Article Type] Review
Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitorsComment Published on 2020-11-162023-07-11 Journal: Platelets [Category] SARS, [키워드] BTK COVID-19 Fcγ-receptor Neutrophils Platelets Thromboinflammation [DOI] 10.1080/09537104.2020.1809647 [Article Type] Comment
Extrapulmonary Clinical Manifestations in COVID-19 PatientsReview Article Published on 2020-11-152022-10-28 Journal: The American Journal of Tropical Medicine and Hygi [Category] COVID-19, SARS, [키워드] acute respiratory syndrome angiotensin-converting enzyme 2 arrhythmia Autoimmunity cells clinical Coagulopathy Complication complications COVID-19 COVID-19 patient Direct disorders dysfunction dysregulated dysregulation Endocrine Epidemiology Extrapulmonary hematological immune responses immune system indirect effect Infection manifestation Manifestations multiple organ dysfunction multiple organ failure Myocardial dysfunction neurological Pathogenesis pathophysiology Pneumonia receptor receptors reported symptomatic patient Symptoms Thromboinflammation viral infection virus [DOI] 10.4269/ajtmh.20-0986 PMC 바로가기 [Article Type] Review Article
COVID-19 patients exhibit reduced procoagulant platelet responsesCOVID-19 환자는 감소된 응고 촉진 혈소판 반응을 나타냅니다.Article Published on 2020-11-012022-09-12 Journal: Journal of thrombosis and haemostasis : JTH [Category] MERS, 진단, [키워드] binding contribute controls COVID-19 COVID-19 patient COVID-19 patients died Donor dysregulated Evidence evidenced examined faster healthy donors in vivo infections mice Microvascular thrombosis Mitochondria mitochondrial Mitochondrial function Phosphatidylserine Platelet platelet activation procoagulant recruited reduced response Result SARS-COV-2 infection significantly Support System thrombin Thromboinflammation thrombosis thrombotic complication university Utah wild-type [DOI] 10.1111/jth.15107 PMC 바로가기 [Article Type] Article
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacyResearch article Published on 2020-11-012022-10-05 Journal: Clinical immunology (Orlando, Fla.) [Category] SARS, 바이오마커, [키워드] abrogate Activation acute respiratory distress AMY-101 anti-inflammatory response ARDS Biomarkers blockade C-reactive protein C3 inhibition C3a C5 blockade C5a candidate drug clinical evidence Clinical finding Cohort complement consequence COVID-19 COVID-19 hyper-inflammation COVID-19 patient COVID-19 therapeutics detrimental drug candidate Drug efficacy eculizumab effector Efficacy elicit exploratory study faster hyper-inflammation IL-6 levels immunopathology immunothrombosis implicated independent indicate inhibitor inhibitory Intervention LDH Lung function lymphocyte monoclonal antibody multi-organ failure NET neutrophil counts Neutrophil extracellular trap offer outcome pathogenic pathway reflected robust SARS-COV-2 infection SC5b-9 serum severe COVID-19 patients Support syndrome therapeutic Thromboinflammation thrombotic trials upstream [DOI] 10.1016/j.clim.2020.108598 [Article Type] Research article